Phenolic	O
fraction	O
of	O
tobacco	O
smoke	O
condensate	O
potentiates	O
benzo	O
[	O
a	O
]	O
pyerene	O
diol	O
epoxide	O
-	O
induced	O
cell	B-Cell
transformation	O
:	O
role	O
of	O
protein	O
kinase	O
C	O
.	O

In	O
this	O
study	O
we	O
separated	O
weakly	O
acidic	O
phenolic	O
components	O
from	O
other	O
neutral	O
,	O
acidic	O
and	O
basic	O
components	O
of	O
tobacco	O
smoke	O
condensate	O
(	O
TSC	O
)	O
and	O
observed	O
that	O
phenolic	O
fraction	O
of	O
TSC	O
significantly	O
increased	O
the	O
number	O
of	O
colonies	B-Cell
of	O
promotion	O
-	O
sensitive	O
JB6	B-Cell
Cl41	I-Cell
cells	I-Cell
that	O
showed	O
anchorage	O
-	O
independent	O
growth	O
on	O
soft	O
agar	O
in	O
response	O
to	O
BPDE	O
(	O
an	O
ultimate	O
carcinogen	O
produced	O
by	O
metabolic	O
activation	O
of	O
the	O
PAH	O
benzo	O
[	O
a	O
]	O
pyrene	O
)	O
.	O

Anchorage	O
-	O
independent	O
cell	B-Cell
growth	O
is	O
indicative	O
of	O
cell	B-Cell
transformation	O
resulting	O
in	O
acquisition	O
of	O
tumorigenic	O
potential	O
.	O

In	O
order	O
to	O
understand	O
the	O
underlying	O
mechanism	O
by	O
which	O
TSC	O
phenolic	O
fraction	O
potentiates	O
BPDE	O
-	O
induced	O
tumorigenicity	O
,	O
we	O
examined	O
its	O
effect	O
on	O
the	O
activation	O
of	O
two	O
transcription	O
factors	O
AP	O
-	O
1	O
and	O
NF	O
-	O
kappaB	O
which	O
are	O
known	O
to	O
be	O
influenced	O
by	O
established	O
tumor	B-Cancer
promoter	O
TPA	O
.	O

BPDE	O
treatment	O
caused	O
induction	O
of	O
both	O
AP	O
-	O
1	O
and	O
NF	O
-	O
kappaB	O
activity	O
as	O
determined	O
by	O
luciferase	O
reporter	O
assay	O
and	O
only	O
NF	O
-	O
kappaB	O
induction	O
in	O
response	O
to	O
BPDE	O
was	O
significantly	O
attenuated	O
by	O
TSC	O
phenolic	O
fraction	O
whereas	O
AP	O
-	O
1	O
induction	O
remains	O
unaltered	O
.	O

Attenuation	O
of	O
NF	O
-	O
kappaB	O
activation	O
by	O
TSC	O
phenolic	O
fraction	O
was	O
associated	O
with	O
significant	O
decrease	O
of	O
intracellular	B-Immaterial_anatomical_entity
PKC	O
substrate	O
phosphorylation	O
in	O
BPDE	O
treated	O
cells	B-Cell
.	O

Non	O
-	O
specific	O
PKC	O
inhibitors	O
staurosporine	O
and	O
bisindolylmaleimide	O
II	O
as	O
well	O
as	O
inhibitors	O
specific	O
to	O
conventional	O
PKCs	O
(	O
Go6976	O
)	O
and	O
PKC	O
-	O
delta	O
(	O
rottlerin	O
)	O
attenuated	O
NF	O
-	O
kappaB	O
activation	O
in	O
BPDE	O
treated	O
cells	B-Cell
to	O
a	O
varying	O
degree	O
indicating	O
a	O
possible	O
link	O
between	O
PKC	O
down	O
-	O
regulation	O
and	O
the	O
attenuation	O
of	O
NF	O
-	O
kappaB	O
activity	O
by	O
TSC	O
phenolic	O
fraction	O
.	O

Treatment	O
of	O
cells	B-Cell
with	O
PKC	O
inhibitors	O
also	O
potentiated	O
anchorage	O
-	O
independent	O
growth	O
of	O
BPDE	O
treated	O
cells	B-Cell
on	O
soft	O
agar	O
.	O

Our	O
data	O
suggest	O
a	O
possible	O
role	O
of	O
PKC	O
down	O
-	O
regulation	O
in	O
potentiation	O
of	O
BPDE	O
-	O
induced	O
tumorogenicity	O
by	O
TSC	O
phenolic	O
fraction	O
.	O

